Response to Letter to the Editor: Meta-Analysis of the Long-term Efficacy and Tolerance of Tadalafil Daily Compared With Tadalafil On-Demand in Treating Men With Erectile Dysfunction
Abstract
The reader said, "In the results section, the authors reported that the tadalafil daily group had a greater increase of IIEF-EF (MD 1⁄4 1.24; 95% CI 1⁄4 0.03e2.44; P 1⁄4 0.04), SEP2 (MD 10.08; 95% CI 1⁄4 9.15e11.01; P < 0.00001) and SEP3 (MD 8.19; 95% CI 1⁄4 2.09e14.29; P < 0.00001) in comparison to tadalafil on-demand, which suggest the superiority of tadalafil daily. However, when we show the results using the forests plots figures, it could be interpreted as the other way due to technical setting of describing forest plot."
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Antioxidant efficacy and the upregulation of Nrf2-mediated HO-1 expression by (+)-lariciresinol, a lignan isolated from Rubia philippinensis, through the activation of p38
- Anti-influenza virus activity of green tea by-products in vitro and efficacy against influenza virus infection in chickens
- Therapeutic Potential of Mesenchymal Stem Cells (MSCs) and MSC-Derived Extracellular Vesicles for the Treatment of Spinal Cord Injury
- The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model
- Enhanced anticancer efficacy of TRAIL-conjugated and odanacatib-loaded PLGA nanoparticles in TRAIL resistant cancer
- In vivo tracking of bioorthogonally labeled T-cells for predicting therapeutic efficacy of adoptive T-cell therapy
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.